Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins...
Leadership
Markus Warmuth M.D.
President, CEO & Director
Philip Nickson J.D., Ph.D.
Chief Business & Legal Officer
Filip Janku M.D., Ph.D.
Chief Medical Officer
Matthew Bowen
Corporate Controller & Principal Accounting Officer
